<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
	<TITLE>$titleTag</TITLE>
<STYLE type="text/css">
   subtoolbar {border-top-width: 0px; border-top-style: none;}


   
 </STYLE>	
</head>
<body>
	
	<table width="940" height="496" border="0" align="center" cellpadding="0" cellspacing="0">
		<tr>
			<td height="489" align="right" valign="top"><SPAN><BR><INPUT type="BUTTON" name="BUTTON" value="< BACK" onclick="javascript: history.go(-1)" /></SPAN><BR>
			<table width="100%">
				<tr valign="top" align="left" style="color:#0066FF">
					<th width="33%">j100851</th>
					<th width="33%">i25662725</th>
					<th width="33%"><A HREF='http://phoenix.jstor.org/Phoenix/toc/secure/issue.html?workType=mod&journalId=10.2307/j100851&issueId=10.2307_i25662725' target='_blank'>PHX Link</A></th>
				</tr>
			</table>
			<P align='left' style='color:#993300'><B><u>10.2307/25662749</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Evidence is mixed regarding how familial predisposition to breast cancer affects the relation between hormone replacement therapy and risk of postmenopausal breast cancer. We investigated whether the risk difference for invasive breast cancer attributable to estrogen plus progesterone replacement therapy is greater among women with a first-degree family history of the disease.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Evidence is mixed regarding how familial predisposition to breast cancer affects the relation between hormone replacement therapy and risk of postmenopausal breast cancer. We investigated whether the risk difference for invasive breast cancer attributable to estrogen plus progesterone replacement therapy is greater among women with a first-degree family history of the disease.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: This study is a longitudinal follow-up of 16,608 postmenopausal women aged 50–79 years who were enrolled between 1993 and 2002 in the Women's Health Initiative randomized trial of estrogen plus progesterone replacement therapy versus placebo.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Three hundred forty-nine cases of invasive breast cancer occurred during a mean follow-up period of 5.6 years. The invasive breast cancer risk difference attributable to the hormone therapy was 0.007 among women with first-degree family history and 0.005 among the others, resulting in a negligible interaction contrast (IC = 0.002; 95% confidence interval = –0.014 to 0.018). The interaction contrast restricted to estrogen-receptor-positive invasive breast cancers was also negligible (IC = –0.006; 95% CI = –0.021 to 0.008).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Family history and estrogen plus progesterone replacement therapy have independent and noninteracting effects on the risk of invasive breast cancer among participants in the Women's Health Initiative randomized trial.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662748</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Many cancers arise from sites of infection and inflammation. Results from animal studies indicate that inflammatory cells may facilitate neoplastic processes by orchestrating the tumor microenvironment. Little is known about the role of inflammation in the etiology of breast cancer. The aim of this study was to examine possible associations between a history of mastitis requiring hospitalization and subsequent risk of breast cancer.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Many cancers arise from sites of infection and inflammation. Results from animal studies indicate that inflammatory cells may facilitate neoplastic processes by orchestrating the tumor microenvironment. Little is known about the role of inflammation in the etiology of breast cancer. The aim of this study was to examine possible associations between a history of mastitis requiring hospitalization and subsequent risk of breast cancer.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: This cohort study of 2,577,565 women used data from several Swedish population-based registers, including the Inpatient Register and the Cancer Register. The risk of breast cancer was assessed by Poisson regression modeling.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: We identified 8411 women in the Inpatient Register with a discharge diagnosis of mastitis. Of these, 106 had a subsequent diagnosis of breast cancer recorded in the Cancer Register. Compared with women who had no recorded mastitis, the incidence rate of breast cancer (regardless of laterality) was higher in women with mastitis, with an incidence rate ratio of 1.23 (95% confidence interval [CI] = 1.02–1.49) following adjustment for age, calendar time, age at first birth and parity. In the group of women among whom information on laterality was available for both the mastitis and the malignancy (n = 87), side of lesions corresponded for 52% (95% CI = 41%–62%), which is what could be expected by chance.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: The overall risk of breast cancer was slightly elevated in women with a history of mastitis recorded in the Inpatient Register. The absence of a correlation between laterality of lesions, however, does not support a causal association between inflammation and the development of breast cancer.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662738</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The short-term effects of particulate matter (PM) on mortality and morbidity differ by geographic location and season. Several hypotheses have been proposed for this variation, including different exposures with air conditioning (AC) versus open windows.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The short-term effects of particulate matter (PM) on mortality and morbidity differ by geographic location and season. Several hypotheses have been proposed for this variation, including different exposures with air conditioning (AC) versus open windows.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Bayesian hierarchical modeling was used to explore whether AC prevalence modified day-to-day associations between PM?? and mortality, and between PM and cardiovascular or respiratory hospitalizations, for those 65 years and older. We considered yearly, summer-only, and winter-only effect estimates and 2 types of AC (central and window units).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Communities with higher AC prevalence had lower PM effects. Associations were observed for cardiovascular hospitalizations and central AC. Each additional 20% of households with central AC was associated with a 43% decrease in PM effects on cardiovascular hospitalization. Central AC prevalence explained 17% of between-community variability in PM effect estimates for cardiovascular hospitalizations.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Higher AC prevalence was associated with lower health effect estimates for PM.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662737</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The role of intergenerational influences on age at menarche has not been explored far beyond the association between mothers' and daughters' menarcheal ages. Small size at birth and childhood obesity have been associated with younger age at menarche, but the influence of maternal overweight or obesity on daughters' age at menarche has not been thoroughly examined.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The role of intergenerational influences on age at menarche has not been explored far beyond the association between mothers' and daughters' menarcheal ages. Small size at birth and childhood obesity have been associated with younger age at menarche, but the influence of maternal overweight or obesity on daughters' age at menarche has not been thoroughly examined.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: In a follow-up study of the prospective Collaborative Perinatal Project, grown daughters were asked in 1987–1991 for their age at menarche. Data from the original Collaborative Perinatal Project (1959–1966) included their mothers' height and prepregnancy weight. In the follow-up study, 597 of 627 daughters had complete menarche and maternal data available and were included in the present analysis. We used polytomous logistic regression to examine the association between maternal overweight (body mass index [BMI] = 25–29.9 km/m²) or obesity (BMI ? 30) and daughter's age at menarche (?12, 12, 13, 14+ years).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Compared with those whose mothers had a BMI less than 25, daughters of obese mothers experienced younger age at menarche (OR for menarche at ?12 years = 3.1 [1.1–9.2]). This association remained after adjusting for maternal age at menarche, maternal parity, socioeconomic status, race, and study site (OR = 3.3 [1.1–10.0]). Effect estimates for maternal overweight were close to the null. There was limited evidence of mediation by small for gestational age or BMI at age 7.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Maternal obesity is associated with younger menarcheal age among daughters in this study, possibly via unmeasured shared factors.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662736</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Few studies have considered the potential utility of clothing size as a predictor of diseases associated with body weight.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Few studies have considered the potential utility of clothing size as a predictor of diseases associated with body weight.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We used data on weight-stable men and women from a subcohort of the Netherlands Cohort Study to assess the correlation of clothing size with other anthropometric variables. Cox regression using the case-cohort approach was performed to establish whether clothing size can predict cancer risk after 13.3 years of follow-up, and if additionally considering body mass index (BMI) in the model improves the prediction.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Trouser and skirt size correlated well with circumference measurements. Skirt size predicted endometrial cancer risk, and this effect was slightly attenuated when BMI was added to the model. Trouser size predicted risk of renal cell carcinoma, regardless of whether BMI was in the model.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Clothing size appears to predict cancer risk independently of BMI, suggesting that clothing size is a useful measure to consider in epidemiologic studies when waist circumference is not available.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662745</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Preeclampsia, a disorder with prominent cardiovascular manifestations, is a cause of maternal, fetal, and infant morbidity and mortality. Chocolate contains compounds that may promote cardiovascular health. A recent study found chocolate consumption during pregnancy, and, particularly, increasing cord serum concentration of theobromine (the primary methylxanthine alkaloid in chocolate), to be associated with reduced occurrence of preeclampsia.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Preeclampsia, a disorder with prominent cardiovascular manifestations, is a cause of maternal, fetal, and infant morbidity and mortality. Chocolate contains compounds that may promote cardiovascular health. A recent study found chocolate consumption during pregnancy, and, particularly, increasing cord serum concentration of theobromine (the primary methylxanthine alkaloid in chocolate), to be associated with reduced occurrence of preeclampsia.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We studied 2769 women who comprised the control group from a case-control study of caffeine metabolites and spontaneous abortion nested within the Collaborative Perinatal Project. These women were pregnant between 1959 and 1966, with liveborn infants of at least 28 weeks' gestation. Serum was drawn at <20 weeks and >26 weeks' gestation, and assayed for theobromine by high-performance liquid chromatography. Odds ratios (ORs) for preeclampsia were estimated using logistic regression, and adjusted for age, education, prepregnant weight, race, parity, smoking, and gestation at blood draw.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Preeclampsia occurred in 68 (2.9%) of 2105 eligible women. Adjusted ORs for preeclampsia were near unity across most third-trimester theobromine concentrations. Adjusted ORs for preeclampsia according to theobromine concentration in serum at <20 weeks' gestation increased with increases in concentration, although estimates were imprecise.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: This study does not support the previous finding that chocolate consumption is associated with a reduced occurrence of preeclampsia. Unmeasured confounding or reverse causation may account for the positive association between early-pregnancy theobromine and preeclampsia.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662735</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Introduction: Among individuals infected with the human immunodeficiency virus (HIV), biomarkers that predict mortality are also used to determine the time when antiretroviral therapy is initiated. No studies have evaluated the impact of the frequency of marker measurements for either their predictive value of mortality or how they may influence inference of the effect of therapy initiation in analyses from observational data.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Introduction: Among individuals infected with the human immunodeficiency virus (HIV), biomarkers that predict mortality are also used to determine the time when antiretroviral therapy is initiated. No studies have evaluated the impact of the frequency of marker measurements for either their predictive value of mortality or how they may influence inference of the effect of therapy initiation in analyses from observational data.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We identified 244 persons who were contemporaneously enrolled in both the AIDS Link to the Intra Venous Experience (an interval cohort) and the Johns Hopkins HIV Clinical Cohort between 1995 and 2004. Data from each study were used separately in 2 ways. We applied time-dependent proportional hazards models to examine the predictive associations between markers and mortality, and marginal structural models to examine the causal inference of therapy on mortality. Biomarkers were used to derive the inverse probability weights.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The timing frequencies of marker measurements in the interval cohort (CD4 interquartile range = 175–194 days) were less heterogeneous than in the clinical cohort (interquartile range = 38–121 days). Despite this, the results were concordant for CD4 (R² = 0.537 [95% confidence interval = 0.345–0.707] and (R² = 0.488 [0.297–0.666], respectively). Similar concordance was found for the HIV-1 RNA and hemoglobin analyses. When evaluating the causal effect of highly active antiretroviral therapy (HAART), the relative hazards were 0.34 for the interval cohort study (95% CI = 0.15–0.77) and 0.27 for the clinical cohort study (0.11–0.66).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Utilizing a unique co-enrollment of patients in 2 different types of cohort studies, we find empirical evidence that inferences drawn from these different structures are similar.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662744</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: A recent study showed that nulliparous women who develop preeclampsia had low concentrations of vitamin D in serum sampled in midpregnancy. The aim of the present study was to estimate the association between intake of vitamin D during pregnancy and the risk of preeclampsia in 23,423 nulliparous pregnant women taking part in the Norwegian Mother and Child Cohort Study.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: A recent study showed that nulliparous women who develop preeclampsia had low concentrations of vitamin D in serum sampled in midpregnancy. The aim of the present study was to estimate the association between intake of vitamin D during pregnancy and the risk of preeclampsia in 23,423 nulliparous pregnant women taking part in the Norwegian Mother and Child Cohort Study.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Participating women answered questionnaires at gestational week 15 (general health questionnaire), at week 22 (food frequency questionnaire), and at week 30 (general health questionnaire). Pregnancy outcomes were obtained from the Medical Birth Registry. Nutrient intake was calculated from foods and dietary supplements. We estimated relative risks as odds ratios, and controlled for confounding with multiple logistic regression.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The odds ratio of preeclampsia for women with a total vitamin D intake of 15–20 ?g/d compared with less than 5 ?g/d was 0.76 (95% confidence interval = 0.60–0.95). Considering only the intake of vitamin D from supplements, we found a 27% reduction in risk of preeclampsia (OR = 0.73 [0.58–0.92]) for women taking 10–15 ?g/d as compared with no supplements. No association was found between intake of vitamin D from the diet alone and the occurrence of preeclampsia.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: These findings are consistent with other reports of a protective effect of vitamin D on preeclampsia development. However, because vitamin D intake is highly correlated with the intake of long chain n-3 fatty acids in the Norwegian diet, further research is needed to disentangle the separate effects of these nutrients.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662747</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Although the association of high temperatures with mortality is well-documented, the association with morbidity has seldom been examined. We assessed the potential impact of hot weather on hospital admissions due to cardiovascular and respiratory diseases in New York City. We also explored whether the weather-disease relationship varies with socio-demographic variables.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Although the association of high temperatures with mortality is well-documented, the association with morbidity has seldom been examined. We assessed the potential impact of hot weather on hospital admissions due to cardiovascular and respiratory diseases in New York City. We also explored whether the weather-disease relationship varies with socio-demographic variables.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Method: We investigated effects of temperature and humidity on health by linking the daily cardiovascular and respiratory hospitalization counts with meteorologic conditions during summer, 1991–2004. We used daily mean temperature, mean apparent temperature, and 3-day moving average of apparent temperature as the exposure indicators. Threshold effects for health risks of meteorologic conditions were assessed by log-linear threshold models, after controlling for ozone, day of week, holidays, and long-term trend. Stratified analyses were used to evaluate temperature-demographic interactions.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: For all 3 exposure indicators, each degree C above the threshold of the temperature-health effect curve (29°C–36°C) was associated with a 2.7%–3.1% increase in same-day hospitalizations due to respiratory diseases, and an increase of 1.4%–3.6% in lagged hospitalizations due to cardiovascular diseases. These increases for respiratory admissions were greater for Hispanic persons (6.1%/°C) and the elderly (4.7%/°C). At high temperatures, admission rates increased for chronic airway obstruction, asthma, ischemic heart disease, and cardiac dysrhythmias, but decreased for hypertension and heart failure.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Extreme high temperature appears to increase hospital admissions for cardiovascular and respiratory disorders in New York City. Elderly and Hispanic residents may be particularly vulnerable to the temperature effects on respiratory illnesses.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662733</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The United Kingdom (UK) underwent a massive epidemic of mumps from 2003 through 2006. The origin and spread was mapped in 350 general practices that used office computers to contribute comprehensive medical information on approximately 3 million patients to the General Practice Research Database (GPRD).</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The United Kingdom (UK) underwent a massive epidemic of mumps from 2003 through 2006. The origin and spread was mapped in 350 general practices that used office computers to contribute comprehensive medical information on approximately 3 million patients to the General Practice Research Database (GPRD).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: The continuous 3-month cumulative incidence of mumps (2003–2006) was estimated by dividing the number of diagnosed cases of mumps each 3 months by the population at risk according to age, region, practice, and calendar time. The effect of the measles, mumps, and rubella (MMR) vaccine was estimated by comparing vaccine exposure of those diagnosed with mumps and those who were not.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: There were 5683 cases of mumps recorded in the Database over the 4-year time period. As the Database represents about 5% of the UK population, we estimate that there were more than 100,000 cases of mumps diagnosed in the UK during these 4 years. The epidemic appears to have started in one practice in Wales in the first 6 months of 2003 and then spread slowly north and east, reaching a peak in 2005. Young adults aged 18–24 years were at the highest risk. There were 3 major MMR vaccination campaigns (1988–1989, 1997, and 2004–2005) that by 2006 provided more than 70% protection against mumps in children younger than 18 years of age. Protection was higher in those who had received 2 doses of the vaccine.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: A comprehensive program of medical information generated by selected general practitioners has provided a sound basis for the real-time recording of the origin, spread, and scope of an infectious disease.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662746</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: We explored the incidence of thromboembolic disease in relatives of women diagnosed with placental abruption, a condition that may be related to disordered coagulation.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: We explored the incidence of thromboembolic disease in relatives of women diagnosed with placental abruption, a condition that may be related to disordered coagulation.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Using data from a multicenter, case-control study of placental abruption, we assessed thromboembolic diseases in first-degree male and female relatives of women with and without abruption. The analysis was restricted to biologic parents and full siblings, below 65 years of age, and corrected for familial clustering.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The prevalence of thromboembolic disease was 7.5% in 852 relatives of 212 placental abruption cases and 4.8% in 792 relatives of 206 controls. This increased risk was driven by an association among sisters of abruption probands (odds ratio = 6.8 [95% confidence interval = 1.8–26.0]), and to a lesser extent, among mothers (2.0 [1.0–4.2]). The risk of thromboembolic diseases was similar among the male relatives of placental abruption cases and controls.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: These data suggest that thromboembolic diseases aggregate within female relatives of women with placental abruption.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662751</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The cognitive reserve hypothesis would predict that use of written Japanese should confer protection against dementia because of the complexity of its ideograms compared with written English. We sought to test this hypothesis in analyses from a longitudinal study of Japanese-American men.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The cognitive reserve hypothesis would predict that use of written Japanese should confer protection against dementia because of the complexity of its ideograms compared with written English. We sought to test this hypothesis in analyses from a longitudinal study of Japanese-American men.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Participants were second-generation Japanese-American men (Nisei) on the island of Oahu, Hawaii, who were seen in 1965 and in subsequent examinations to detect dementia beginning in 1991–1993. Use of spoken and written Japanese was self-reported in 1965 (Analyses 1 and 2), and midlife use of written Japanese and written English was self-reported in 1994–1996 (Analysis 3). We analyzed prevalent dementia outcomes in 1991–1993 (Analysis 1, n = 3139) using logistic regression, and incident dementia outcomes in 1994–2002 (Analysis 2, n = 2299) and in 1997–2002 (Analysis 3, n = 1655) using Cox proportional hazards regression. Dementia outcomes included all-cause dementia, probable and possible Alzheimer disease, and probable vascular dementia. We adjusted models for probable and possible confounders.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Participants who reported proficiency with written Japanese were older and had lower incomes. For Analysis 1, there were 154 prevalent cases of dementia, 74 of Alzheimer disease, and 43 of vascular dementia; for Analysis 2, 236 incident cases of dementia, 138 of Alzheimer disease, and 45 of vascular dementia; and for Analysis 3, 125 incident cases of dementia, 80 of Alzheimer disease, and 20 of vascular dementia. There was no relationship in adjusted models between self-reported proficiency with written Japanese and any dementia outcomes.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Proficiency with written Japanese does not appear to be protective for dementia.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662742</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Neither macro- nor micronutrient supplements have been clearly demonstrated to reduce the risk of preterm birth. However, there has been little attention to carotenoids, tocopherols, and long-chain fatty acids other than n-3 polyunsaturates.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Neither macro- nor micronutrient supplements have been clearly demonstrated to reduce the risk of preterm birth. However, there has been little attention to carotenoids, tocopherols, and long-chain fatty acids other than n-3 polyunsaturates.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We conducted a case—control study nested in a large (n = 5337) prospective, multicenter cohort. All cohort women had an interview, examination, and venipuncture at 24–26 weeks' gestation. Frozen plasma samples in spontaneous preterm births (n = 207) and approximately 2-term controls per case (n = 443) were analyzed for carotenoids, retinol, tocopherols, and long-chain fatty acids. Fresh placentas were fixed, stained, and assessed (without knowledge or pregnancy outcome) for histologic evidence of infection or inflammation, decidual vasculopathy, and infarction.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: High (above the median) plasma concentrations of ?- and ?-carotene, ?- and ?-cryptoxanthin, and lycopene were all associated with reductions in risk of spontaneous preterm birth, with evidence of dose-response effects across quartiles. Modest increases in risk were observed with elevated total monounsaturated, total polyunsaturated, and total n-6 polyunsaturated long-chain fatty acids concentrations. Paradoxically, a high ?-tocopherol concentration was associated with increased preterm birth risk (adjusted odds ratio = 1.8 [95% confidence interval = 1.2–2.6]). Only one of the studied micro-nutrients (lutein) was independently associated with a reduced risk of decidual vasculopathy (0.5 [0.3–0.9]).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Carotenoids and long-chain fatty acids warrant further investigation in in vitro, animal, and human studies of preterm birth.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662743</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Folic acid is known to reduce risk of neural tube defects (NTDs). Even so, NTDs continue to occur despite individual supplementation or population fortification with folic acid. We investigated other nutrients related to one-carbon metabolism that may affect NTD risk.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Folic acid is known to reduce risk of neural tube defects (NTDs). Even so, NTDs continue to occur despite individual supplementation or population fortification with folic acid. We investigated other nutrients related to one-carbon metabolism that may affect NTD risk.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: This prospective study included data from more than 180,000 pregnant women in California from 2003 through 2005. Midpregnancy serum specimens were linked with delivery information regarding the presence of a NTD, another structural malformation, or no malformation in the fetus. We identified 80 NTD-affected pregnancies (cases) and we randomly selected 409 pregnancy controls. Serum specimens were tested for methylmalonic acid, homocysteine, cysteine, methionine, total choline, betaine, cystathionine, vitamin B6, folate, vitamin B12, riboflavin, and creatinine.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: We observed elevated NTD risks associated with lower levels of total choline, and reduced risks with higher levels of choline. Specifically, we observed an odds ratio of 2.4 (95% confidence interval = 1.3–4.7) associated with the lowest decile and an odds ratio of 0.14 (0.02–1.0) associated with the highest decile, both relative to the 25th—74th percentiles of the control distribution. These data did not show meaningful differences between cases and controls for any other analytes.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: This is the first study to investigate total choline in NTD-affected pregnancies. Our findings for choline, for which low levels were a risk factor and higher levels were a protective factor for NTDs, may offer a useful clue toward understanding the complex etiologies of NTDs in an era of folic acid fortification of the food supply.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662740</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: An emerging body of evidence suggests that ambient levels of air pollution during pregnancy are associated with preterm birth.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: An emerging body of evidence suggests that ambient levels of air pollution during pregnancy are associated with preterm birth.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: To further investigate these relationships we used vital record data to construct a retrospective cohort of 476,489 births occurring between 1994 and 2004 in 5 central counties of metropolitan Atlanta. Using a time-series approach, we examined aggregated daily counts of preterm birth in relation to ambient levels of carbon monoxide, nitrogen dioxide, sulfur dioxide, ozone, particulate matter < 10 ?m in diameter (PM??), particulate matter <2.5 ?m in diameter (PM), and speciated PM measurements. Daily pollutant levels in 5-county Atlanta were characterized using a population-weighted spatial average of air quality monitors in the study area. We also examined ambient concentrations at individual monitors in analyses limited to mothers with residential geocodes within 4 miles of each monitor. Relationships between average pollution levels during 3 gestational windows of interest were modeled using Poisson generalized linear models. Results were adjusted for seasonal and long-term time trends.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Although most results were null, there were 3 positive associations between ambient pollution levels and preterm birth in the 4-mile capture-area analyses. Daily preterm birth rates were associated with average NO? concentrations in the preceding 6 weeks and with average PM sulfate and PM water-soluble metal concentrations in the preceding week.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Results provide limited support for late-pregnancy effects of ambient air pollution on preterm birth.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662741</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: A strength of time-series analyses is the inherent control of individual-level risk factors that do not vary temporally. However, in studies of adverse pregnancy outcomes, risk factors considered time-invariant at the individual level may vary seasonally when aggregated into a pregnancy risk set. To illustrate, we describe the seasonal patterns of birth in Atlanta and demonstrate how these patterns could lead to confounding in time-series studies of seasonally-varying exposures and preterm birth.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: A strength of time-series analyses is the inherent control of individual-level risk factors that do not vary temporally. However, in studies of adverse pregnancy outcomes, risk factors considered time-invariant at the individual level may vary seasonally when aggregated into a pregnancy risk set. To illustrate, we describe the seasonal patterns of birth in Atlanta and demonstrate how these patterns could lead to confounding in time-series studies of seasonally-varying exposures and preterm birth.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: The study cohort included all births in 20-county metropolitan Atlanta delivered during the period 1994–2004 (n = 715,875). We assessed the seasonal patterns of estimated conception and birth for the full cohort and for subgroups stratified by sociodemographic factors. Based on the observed patterns, we quantified the degree of potential confounding created by (1) differences in the gestational age distribution in the risk set across calendar months and (2) differences in the sociodemographic composition of the risk set across calendar months.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The overall seasonal pattern of birth was characterized by a peak in August—September and troughs in April—May and November—January. Seasonal patterns differed among racial and ethnic groups, maternal education levels, and marital status. As a consequence of these seasonal patterns, systematic seasonal differences in the gestational age distribution and the sociodemographic composition of the risk set led to differences in expected rates of preterm birth across calendar months.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Time-series investigations of seasonally-varying exposures and adverse pregnancy outcomes should consider the potential for bias due to seasonal heterogeneity in the risk set.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662750</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Infant deaths cluster in families, but beyond infancy, little is known about familial aggregation of premature deaths. We hypothesized that an individual's risk of premature death would be influenced by prior premature deaths of any age in family members.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Infant deaths cluster in families, but beyond infancy, little is known about familial aggregation of premature deaths. We hypothesized that an individual's risk of premature death would be influenced by prior premature deaths of any age in family members.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: For all Danish residents registered in the Civil Registration System, 1968–2005, information was linked to the Causes of Death Register and the Danish Family Relation Database, yielding a cohort of 4,870,821 persons linked to one or more relatives (93 million persons-years and 73,278 deaths). We used log-linear Poisson regression to estimate mortality rate ratios (relative risks) for premature death (before age 40 years) in persons with a family history of premature death, compared with persons without such a history.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Persons with a family history of premature death were 46% more likely themselves to die prematurely than persons without such a family history (relative risk [RR] = 1.46 [95% confidence interval = 1.42–1.50]). Relative risks were higher for concordant age at death, a close kinship relation, and similar causes of death. As expected, certain natural causes clustered among first-degree relatives (RRs ranged from 1.81–618), but unnatural causes of death, such as nonsimultaneous motor vehicle injuries, other injuries, and suicides, also clustered (RRs = 1.80, 3.53, and 4.23, respectively). Previous family history of premature death in a first-degree relative also increased the risk of dying from another cause (overall RR = 2.08 in infancy and 1.33 between ages 1 and 39).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Premature deaths cluster in families, for both similar and dissimilar causes.</TD></TR></table>
				
		</td>
		</tr>
	</table>		
</body>
</html>
